Q: What need is Precision BioSciences addressing? A: Precision’s ARCUS genome editing technology is a proprietary, non-CRIPSR platform that has applications across cell therapy, gene therapy, and agriculture. We are able to edit everything from plants to primates, so prioritizing projects is an imporant part...
Q: Why is preemptive pharmacogenetics testing important in the context of personalized medicine? A: We estimated that pharmacogenetic test results can impact the use of nearly 100 drugs, accounting for up to 18% of current prescriptions. Therefore, having pharmacogenetic test results already “in hand” at the...
Q: What need is Datavant addressing? A: While the volume of health data grows precipitously year over year, our ability to make use of that data is not keeping pace. There are many aspects to the inherent challenges and opportunities of this data explosion...
In the age of big DNA data, it is important to remember that accumulating large amounts of data is not enough. Equally important is keeping the DNA data that participants provide as diverse as possible to allow us to generate answers to questions about how...
Q: What need is Exact Sciences Corporation addressing? A: Exact Sciences’ mission is to improve patient outcomes through the early detection of cancer. We are especially focused on developing highly accurate, minimally invasive screening tests and technologies....
Q: What need is Biocept, Inc addressing? A: Physicians are not receiving all the genomic information needed for precision medicine therapeutic decision making so some patients potentially miss out on targeted therapies that could save or extend their lives....
Q: How do you select startup companies you invest in? What are values you are looking for both in the companies and the leadership teams? A: This answer is more of a philosophical one rather than a simple listing of ingredients, even though the latter might...
The microbiome significantly impacts human health, playing a crucial role in maintaining health and preventing disease. It influences endocrinology, physiology, and even neurology, altering the outcome of many different disease states, and it has been shown to augment drug responses and tolerance. In parallel to...
Q: What is your vision for personalized care? A: While the term “personalized care” has become popular contemporary with the maturation of genomic medicine, it is clear that the entire context of care – including social, behavioral, and environmental factors – drives the outcomes we are...
Q1a: You are the Deputy Director of the All of Us Research Program. What is your role as the deputy director and why is this initiative so important? A: As deputy director, my primary role is to work closely with the All of Us Director Eric...
